Oframax 250 mg I.V Vial

Warning: the doses below are the general doses for ceftriaxone and are not product specific. Use the intravenous vials for intravenous injections and the intramuscular vials for intramuscular injections. -Acute Otitis media: IM, IV: 1 to 2 g once daily for 3 days. -Pneumonia: Inpatients without risk factors for P. aeruginosa: IV: 1 to 2 g once daily in combination with other appropriate agent(s). Total duration (which may include oral step-down therapy) is for a minimum of 5 days; patients should be clinically stable with normal vital signs prior to discontinuation. -Salmonella infection: Enteric fever: IV: 2 g every 12 to 24 hours for 10 to 14 days. -Chronic obstructive pulmonary disease: IV: 1 g once daily for 5 to 7 days. -Diabetic foot infection: IV: 1 to 2 g once daily in combination with other appropriate agents. Duration (which may include oral step-down therapy) is usually 2 to 4 weeks. -Bacterial Meningitis: IV: 2 g every 12 hours. Treatment duration is 7 to 21 days, depending on causative pathogen(s) and clinical response. -Sexually transmitted infections: 1-Gonococcal infection: In case of uncomplicated gonorrhea: IM: 500 mg as a single dose; 1 g is recommended for patients weighing ≥150 kg. While in case of disseminated gonococcal infection: IV (preferred), IM: 1 g once daily. 2- Neurosyphilis: IM, IV: 1 to 2 g once daily for 10 to 14 days. -Complicated Urinary tract infection: Inpatients: IV: 1 g once daily. Switch to an appropriate oral regimen once symptoms improve. Total duration of therapy ranges from 5 to 14 days and depends on clinical response and the antimicrobial chosen to complete the regimen. While in case of outpatients: IV, IM: 1 g once, followed by 5 to 14 days of appropriate oral therapy. -Skin and soft tissue infection: IV: 1 to 2 g once daily, usually as part of an appropriate combination regimen. Duration varies by extent of infection, clinical response. -Pediatric dosing: See dosage and administration.